J. Arnt

3.4k total citations · 1 hit paper
54 papers, 2.9k citations indexed

About

J. Arnt is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, J. Arnt has authored 54 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cellular and Molecular Neuroscience, 27 papers in Molecular Biology and 11 papers in Psychiatry and Mental health. Recurrent topics in J. Arnt's work include Neurotransmitter Receptor Influence on Behavior (33 papers), Neuroscience and Neuropharmacology Research (27 papers) and Receptor Mechanisms and Signaling (19 papers). J. Arnt is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (33 papers), Neuroscience and Neuropharmacology Research (27 papers) and Receptor Mechanisms and Signaling (19 papers). J. Arnt collaborates with scholars based in Denmark, Israel and France. J. Arnt's co-authors include John Hyttel, A. V. Christensen, Jørgen Scheel‐Krüger, J.‐J. Larsen, G. Magelund, Ole Lander Svendsen, K. Fredricson Over�, Michael Didriksen, Bruno Pouzet and Connie Sánchez and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Neuropsychopharmacology and Life Sciences.

In The Last Decade

J. Arnt

53 papers receiving 2.8k citations

Hit Papers

Do Novel Antipsychotics Have Similar Pharmacological Char... 1998 2026 2007 2016 1998 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence
    1998 596 citations J. Arnt Neuropsychopharmacology profile →

Peers

J. Arnt
Mark S. Kleven France
Jan B. De Vries Netherlands
Louis A. Chiodo United States
Nicholas Waters Sweden
P. Slater United Kingdom
G E Duncan United States
Rita Raisman France
Frank D. Yocca United States
Junji Ichikawa United States
Jørn Arnt Denmark
Mark S. Kleven France
J. Arnt
Citations per year, relative to J. Arnt J. Arnt (= 1×) peers Mark S. Kleven

Countries citing papers authored by J. Arnt

Since Specialization
Citations

This map shows the geographic impact of J. Arnt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Arnt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Arnt more than expected).

Fields of papers citing papers by J. Arnt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Arnt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Arnt. The network helps show where J. Arnt may publish in the future.

Co-authorship network of co-authors of J. Arnt

This figure shows the co-authorship network connecting the top 25 collaborators of J. Arnt. A scholar is included among the top collaborators of J. Arnt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Arnt. J. Arnt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hyttel, John, A. V. Christensen, & J. Arnt. (2015). Neuroleptic Classification: Implications for Tardive Dyskinesia. PubMed. 21. 49–64.
2.
Dahan, Lionel, Ouissame Mnie‐Filali, J. Arnt, P. Hertel, & Nasser Haddjeri. (2006). P.3.d.001 Effects of bifeprunox on the rat ventral tegmental area dopamine and dorsal raphe serotonin neuronal activity. European Neuropsychopharmacology. 16. S429–S430. 2 indexed citations
3.
Hesselink, M.B., et al.. (2003). DU127090: A novel partial dopamine agonist with antipsychotic activity partial agonist character in functional assays in vivo. Schizophrenia Research. 60(1). 117–117. 1 indexed citations
4.
Pouzet, Bruno, Michael Didriksen, & J. Arnt. (2002). Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacology Biochemistry and Behavior. 71(4). 635–643. 51 indexed citations
5.
Pouzet, Bruno, Michael Didriksen, & J. Arnt. (2002). Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia. Pharmacology Biochemistry and Behavior. 71(4). 655–665. 106 indexed citations
6.
Arnt, J.. (1998). Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence. Neuropsychopharmacology. 18(2). 63–101. 596 indexed citations breakdown →
7.
8.
Meier, Eddi, J. Arnt, Kristen Frederiksen, et al.. (1995). Pharmacological characterization of Lu 25-109-T, a compound with M 1 -agonistic and M 2 /M 3 -antagonistic effects on muscarinic receptors.. Life Sciences. 1006. 2 indexed citations
9.
Meier, Eddi, J. Arnt, Kristen Frederiksen, et al.. (1995). Pharmacological characterization of Lu 25-109-T, a compound with M1 agonistic and effects on muscarinic receptors. Life Sciences. 56(11-12). 1006–1006. 3 indexed citations
10.
Weiner, I., et al.. (1994). The effects of the new antipsychotic, sertindole, on latent inhibition in rats. Behavioural Pharmacology. 5(2). 119–124. 22 indexed citations
11.
12.
Arnt, J. & John Hyttel. (1990). Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques. Journal of Neural Transmission. 80(1). 33–50. 30 indexed citations
13.
Hyttel, John, et al.. (1989). Selective Dopamine D1 and D2 Receptor Antagonists. PubMed. 7. 109–122. 15 indexed citations
14.
15.
Arnt, J. & John Hyttel. (1988). Behavioral Differentiation between Effects elicited at Dopamine D-1 and D-2 Receptors in Rats with Normosensitive DA Receptors. Pharmacopsychiatry. 21(1). 24–27. 15 indexed citations
16.
Hyttel, John & J. Arnt. (1987). Characterization of binding of3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions. Journal of Neural Transmission. 68(3-4). 171–189. 53 indexed citations
17.
Hyttel, John, J.‐J. Larsen, A. V. Christensen, & J. Arnt. (1985). Receptor-Binding Profiles of Neuroleptics. PubMed. 2. 9–18. 116 indexed citations
18.
Christensen, A. V., J. Arnt, & Ole Lander Svendsen. (1985). Pharmacological Differentiation of Dopamine D-1 and D-2 Antagonists After Single and Repeated Administration. PubMed. 2. 182–190. 18 indexed citations
19.
Scheel‐Krüger, Jørgen, J. Arnt, G. Magelund, et al.. (1980). Behavioural functions of GABA in basal ganglia and limbic system. Brain Research Bulletin. 5. 261–267. 56 indexed citations
20.
Scheel‐Krüger, Jørgen, J. Arnt, & G. Magelund. (1977). Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra. Neuroscience Letters. 4(6). 351–356. 243 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark S. Kleven Breakdown of academic impact, for papers by Jan B. De Vries Breakdown of academic impact, for papers by Louis A. Chiodo Breakdown of academic impact, for papers by Nicholas Waters Breakdown of academic impact, for papers by P. Slater Breakdown of academic impact, for papers by G E Duncan Breakdown of academic impact, for papers by Rita Raisman Breakdown of academic impact, for papers by Frank D. Yocca Breakdown of academic impact, for papers by Junji Ichikawa Breakdown of academic impact, for papers by Jørn Arnt
Rankless by CCL
2026